Table of Contents
Journal of Allergy
Volume 2016, Article ID 9040319, 7 pages
Research Article

A Simple Allergist-Led Intervention Improves Resident Training in Anaphylaxis

1Division of Allergy & Immunology, Hofstra Northwell School of Medicine, 865 Northern Boulevard, Suite 101, Great Neck, NY 11021, USA
2Center for Immunology and Inflammation, Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY 11030, USA
3Pediatric Allergy & Immunology, Stony Brook Children’s Hospital, T-11, Room 080, Stony Brook, NY 11794, USA
4Division of Allergy & Immunology, University of South Florida, 140 7th Avenue South, CRI 4008, St. Petersburg, FL 33701, USA
5ENT & Allergy Associates, 261 Fifth Avenue, Suite 901, New York, NY 10016, USA
6ProHealth Care LLP, 2 Lincoln Avenue, No. 302, Rockville Centre, NY 11570, USA
7Biostatistics Unit, Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY 11030, USA

Received 28 October 2015; Accepted 24 January 2016

Academic Editor: Sebastian L. Johnston

Copyright © 2016 Artemio M. Jongco et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Physicians underrecognize and undertreat anaphylaxis. Effective interventions are needed to improve physician knowledge and competency regarding evidence-based anaphylaxis diagnosis and management (ADAM). We designed and evaluated an educational program to improve ADAM in pediatrics, internal medicine, and emergency medicine residents from two academic medical centers. Anonymous questionnaires queried participants’ demographics, prior ADAM clinical experience, competency, and comfort. A pretest assessing baseline knowledge preceded a 45-minute allergist-led evidence-based presentation, including practice with epinephrine autoinjectors, immediately followed by a posttest. A follow-up test assessed long-term knowledge retention twelve weeks later. 159 residents participated in the pretest, 152 participated in the posttest, and 86 participated in the follow-up test. There were no significant differences by specialty or site. With a possible score of 10, the mean pretest score (7.31 ± 1.50) was lower than the posttest score (8.79 ± 1.29) and follow-up score (8.17 ± 1.72) ( for both). Although participants’ perceived confidence in diagnosing or managing anaphylaxis improved from baseline to follow-up ( for both), participants’ self-reported clinical experience with ADAM or autoinjector use was unchanged. Allergist-led face-to-face educational intervention improves residents’ short-term knowledge and perceived confidence in ADAM. Limited clinical experience or reinforcement contributes to the observed decreased knowledge.